Sort   by:  
 Page size 
UnknownPrexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia.
Not available
S-EPMC5288194 | biostudies-literature
UnknownIn vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia.
Not available
S-EPMC4635624 | biostudies-literature
UnknownSynergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia.
Not available
S-EPMC6895917 | biostudies-literature
UnknownTargeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia.
Not available
S-EPMC6090987 | biostudies-literature
UnknownPatient-reported outcomes of palatal donor site healing using four different wound dressing modalities following free epithelialized mucosal grafts: A four-arm randomized controlled clinical trial.
Not available
S-EPMC10087796 | biostudies-literature
UnknownCortical-like mini-columns of neuronal cells on zinc oxide nanowire surfaces.
Not available
S-EPMC6411964 | biostudies-literature
UnknownExploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells.
Not available
S-EPMC10406704 | biostudies-literature
UnknownMS-based proteomic analysis of cardiac response to hypoxia in the goldfish (Carassius auratus).
Not available
S-EPMC6908699 | biostudies-literature
UnknownConstitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma.
Not available
S-EPMC4466634 | biostudies-literature
UnknownNF-κB inhibition reveals a novel role for HGF during skeletal muscle repair.
Not available
S-EPMC4650539 | biostudies-literature
Sort   by:  
 Page size